Icon

RAVICTI (nda203284)- (1.1GM/ML)

GLYCEROL PHENYLBUTYRATE HORIZON THERAP US
1.1GM/ML
Yes Yes
2032-Mar-09 Expired
2020-Feb-01 None
None No
RAVICTI is a nitrogen-binding agent indicated for chronic management of patients with urea cycle disorders (UCDs) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. RAVICTI must be used with dietary protein restriction and, in some cases, dietary supplements.
0 2 0
Total Other Developers 5
Drugs with Suitability No
1.1GM/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.